- Home
- DMAC vs MITT Comparison
DMAC vs MITT Comparison
Compare DMAC & MITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMAC
- MITT
- Stock Information
- Founded
- DMAC 2000
- MITT 2011
- Country
- DMAC United States
- MITT United States
- Employees
- DMAC N/A
- MITT N/A
- Industry
- DMAC Biotechnology: Pharmaceutical Preparations
- MITT Real Estate Investment Trusts
- Sector
- DMAC Health Care
- MITT Real Estate
- Exchange
- DMAC Nasdaq
- MITT Nasdaq
- Market Cap
- DMAC 172.7M
- MITT 199.8M
- IPO Year
- DMAC N/A
- MITT 2011
- Fundamental
- Price
- DMAC $4.18
- MITT $6.65
- Analyst Decision
- DMAC Strong Buy
- MITT Strong Buy
- Analyst Count
- DMAC 3
- MITT 5
- Target Price
- DMAC $7.00
- MITT $8.00
- AVG Volume (30 Days)
- DMAC 46.2K
- MITT 202.5K
- Earning Date
- DMAC 11-13-2024
- MITT 11-05-2024
- Dividend Yield
- DMAC N/A
- MITT 11.44%
- EPS Growth
- DMAC N/A
- MITT 269.43
- EPS
- DMAC N/A
- MITT 2.09
- Revenue
- DMAC N/A
- MITT $80,741,000.00
- Revenue This Year
- DMAC N/A
- MITT N/A
- Revenue Next Year
- DMAC N/A
- MITT $14.66
- P/E Ratio
- DMAC N/A
- MITT $3.18
- Revenue Growth
- DMAC N/A
- MITT 17.98
- 52 Week Low
- DMAC $2.14
- MITT $5.09
- 52 Week High
- DMAC $4.95
- MITT $7.95
- Technical
- Relative Strength Index (RSI)
- DMAC 48.23
- MITT 30.16
- Support Level
- DMAC $3.96
- MITT $6.59
- Resistance Level
- DMAC $4.21
- MITT $7.16
- Average True Range (ATR)
- DMAC 0.18
- MITT 0.19
- MACD
- DMAC -0.02
- MITT -0.03
- Stochastic Oscillator
- DMAC 50.00
- MITT 8.57
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
About MITT AG Mortgage Investment Trust Inc.
AG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long-term through dividends and capital appreciation. It also focuses on investing in residential mortgage-backed securities (RMBS) issued or guaranteed by a government sponsored enterprise.